Educational Wellness Information Only
This platform provides peer-reviewed research summaries and educational content about peptides for wellness and optimization purposes. Nothing on this site is intended as medical advice, diagnosis, or treatment. We do not claim any peptide can diagnose, treat, cure, or prevent any disease. Always consult a licensed healthcare provider before beginning any wellness protocol.
Statements on this site have not been evaluated by the FDA. Compounded preparations are subject to applicable state and federal regulations. Availability and eligibility vary.
Cerebrolysin vs Pinealon
An educational, source-based comparison of Cerebrolysin and Pinealon — how each peptide works, what it's researched for, and what to know before going deeper.
Porcine-derived peptide mixture researched in neurologic recovery.
A mixture of low-molecular-weight peptides and amino acids derived from purified porcine brain tissue. Research suggests neurotrophic-like activity mimicking BDNF, NGF, and GDNF signaling.
- Ischemic stroke recovery
- Traumatic brain injury
- Vascular dementia and Alzheimer's adjunct
- • Approved in many countries; not FDA-approved in the US.
- • Mixture composition is not fully characterized.
Short peptide bioregulator researched for cognition and aging.
A synthetic tripeptide (Glu-Asp-Arg) in the Khavinson short-peptide bioregulator family. Research from Russian gerontology groups proposes gene-expression modulation linked to neuronal survival and cognitive performance.
- Cognitive aging in rodent models
- Neuronal apoptosis under oxidative stress
- Circadian and neuroendocrine regulation
- • Most evidence from Russian literature; independent replication is limited.
- • Not FDA-approved.
Trial-evidence rating
Educational grade reflecting how many peer-reviewed studies and FDA actions we cite for each peptide. Not a clinical recommendation.
Early-stage research; conclusions are tentative.
Early-stage research; conclusions are tentative.
Study-by-study comparison
| Peptide | Study | Source | Year | Summary |
|---|---|---|---|---|
| Cerebrolysin | Cerebrolysin in acute ischemic stroke (CARS trial) | Stroke | 2016 | Improved early motor recovery in combination with rehabilitation. |
| Pinealon | Pinealon protects neurons from oxidative stress | Bulletin of Experimental Biology and Medicine | 2012 | Reduced apoptosis markers in cultured neurons under H2O2 challenge. |
Side-effect & safety grid
- Approved in many countries; not FDA-approved in the US.
- Mixture composition is not fully characterized.
- Most evidence from Russian literature; independent replication is limited.
- Not FDA-approved.
Educational summary of considerations reported in research literature — not a complete list of adverse events. Discuss with a licensed clinician before any use.
Cerebrolysin vs Pinealon — Key differences
- Class: Cerebrolysin is classified as Neurotrophic · Mixture, while Pinealon is Bioregulator · Neuroprotection.
- Primary research focus: Cerebrolysin — ischemic stroke recovery; Pinealon — cognitive aging in rodent models.
- Tag: Cognition · Neuroprotection vs Cognition · Longevity.